L-Phenylalanine (JP14) en es it fr

L-Phenylalanine (JP14) Brand names, L-Phenylalanine (JP14) Analogs

L-Phenylalanine (JP14) Brand Names Mixture

  • No information avaliable

L-Phenylalanine (JP14) Chemical_Formula

C9H11N1O2

L-Phenylalanine (JP14) RX_link

No information avaliable

L-Phenylalanine (JP14) fda sheet

L-Phenylalanine (JP14) msds (material safety sheet)

http://www.jtbaker.com/msds/englishhtml/p2345.htm

L-Phenylalanine (JP14) Synthesis Reference

No information avaliable

L-Phenylalanine (JP14) Molecular Weight

165.191 g/mol

L-Phenylalanine (JP14) Melting Point

No information avaliable

L-Phenylalanine (JP14) H2O Solubility

Slight (0.1-1%)

L-Phenylalanine (JP14) State

Solid, White crystalline powder

L-Phenylalanine (JP14) LogP

-1.496

L-Phenylalanine (JP14) Dosage Forms

Capsule, powder and tablet

L-Phenylalanine (JP14) Indication

L-phenylalanine may be helpful in some with depression. It may also be useful in the treatment of vitiligo. There is some evidence that L-phenylalanine may exacerbate tardive dyskinesia in some schizophrenic patients and in some who have used neuroleptic drugs.

L-Phenylalanine (JP14) Pharmacology

Used by the brain to produce Norepinephrine, a chemical that transmits signals between nerve cells and the brain; keeps you awake & alert; reduces hunger pains; functions as an antidepressant and helps improve memory.

L-Phenylalanine (JP14) Absorption

Absorbed from the small intestine by a sodium dependent active transport process

L-Phenylalanine (JP14) side effects and Toxicity

L-phenylalanine will exacerbate symptoms of phenylketonuria if used by phenylketonurics. L-phenylalanine was reported to exacerbate tardive dyskinesia when used by some with schizophrenia.

L-Phenylalanine (JP14) Patient Information

No information avaliable

L-Phenylalanine (JP14) Organisms Affected

Humans and other mammals